Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma (ARTIST)
The aim of the study is to evaluate the efficacy of ciclesonide in patients with persistent asthma over 3 months, especially in the cold season. Ciclesonide will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of ciclesonide.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Ciclesonide for the Therapy of Asthma During the Cold Season.|
- FEV1, symptom score assessment [ Time Frame: within 3 months ]
- Handling of the metered-dose inhaler, safety and tolerability [ Time Frame: within 3 months ]
|Study Start Date:||January 2008|
|Study Completion Date:||August 2008|
|Primary Completion Date:||August 2008 (Final data collection date for primary outcome measure)|
This is an observational study. Therefore, the physician decides about dosage according to individual needs.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00608218
Show 153 Study Locations
|Study Director:||Dr. Thomas D. Bethke, PhD, MD||Nycomed Deutschland GmbH, 78467 Konstanz, Germany|